TDOC insider files Form 144 to sell 50,145 shares

Teladoc Health (TDOC) insider sale notice: a proposal to sell 50,145 common shares tied to restricted stock vesting on 02/27/2026 as compensation.

Accepted by SEC EDGAR 03/02/2026 - 05:10 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Teladoc Health (TDOC) insider sale notice: a proposal to sell 50,145 common shares tied to restricted stock vesting on 02/27/2026 as compensation. The filing also records a prior sale of 17,138 common shares on 12/11/2025 by Charles Divita for $130,836.63.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TDOC Form 144 disclose about shares to be sold?

The filing discloses a proposed sale of 50,145 common shares tied to restricted stock vesting on 02/27/2026. These shares are listed as compensation that vested on that date and are identified for sale in the notice.

Who sold shares for TDOC in the past three months?

The excerpt shows that Charles Divita sold 17,138 common shares on 12/11/2025 for $130,836.63. This sale is recorded in the "Securities Sold During The Past 3 Months" section.

Are the proposed TDOC shares from an issuer compensation source?

Yes; the filing lists the 50,145 shares as resulting from restricted stock vesting and classifies the transaction type as Compensation with the vesting date 02/27/2026.

Which broker or agent is listed on the TDOC Form 144?

The notice names Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI, and indicates the securities trade venue as NYSE in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347535
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	DIVITA CHARLES III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50145	256576.92	178396434	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Restricted Stock Vesting	Issuer			50145	02/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Divita 155 E 44th Street Suite 1700 New York NY 10017	Common	12/11/2025	17138	130836.63

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Charles Divita
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)